MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
2008

Elevated MAO-B in Mouse Brain Astrocytes Causes Parkinson's Disease Symptoms

Sample size: 5 publication 10 minutes Evidence: high

Author Information

Author(s): Mallajosyula Jyothi K., Kaur Deepinder, Chinta Shankar J., Rajagopalan Subramanian, Rane Anand, Nicholls David G., Di Monte Donato A., Macarthur Heather, Andersen Julie K.

Primary Institution: Buck Institute for Age Research

Hypothesis

Elevations in astrocytic MAO-B can directly contribute to pathologies observed in Parkinson's disease.

Conclusion

The study demonstrates that increased levels of astrocytic MAO-B lead to significant dopaminergic neuron loss and other Parkinson's disease-related pathologies.

Supporting Evidence

  • Elevated MAO-B levels in astrocytes led to a 40% loss of dopaminergic neurons in the substantia nigra.
  • Increased oxidative stress was observed in dopaminergic neurons due to elevated MAO-B.
  • Treatment with the MAO-B inhibitor deprenyl prevented dopaminergic neuron loss.
  • The study provides a novel model for exploring Parkinson's disease mechanisms.

Takeaway

When certain brain cells have too much of a protein called MAO-B, it can hurt other brain cells and cause problems like those seen in Parkinson's disease.

Methodology

The researchers created genetically engineered mice with increased MAO-B levels in astrocytes and observed the effects on dopaminergic neurons and related pathologies.

Limitations

The study primarily focuses on a mouse model, which may not fully replicate human Parkinson's disease.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001616

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication